" /> Tidutamab - CISMeF





Preferred Label : Tidutamab;

NCIt synonyms : Anti-SSTR2 x Anti-CD3 Monoclonal Antibody XmAb18087;

NCIt definition : A humanized, Fc domain-containing, bispecific monoclonal antibody targeting human CD3, a T-cell surface antigen, and somatostatin receptor 2 (SSTR2), a tumor-associated antigen (TAA) expressed on certain cancer cells, with potential antineoplastic activity. Upon administration, tidutamab binds to both T-cells and SSTR2-expressing cancer cells. The resulting cross-linkage may trigger a potent cytotoxic T-lymphocyte (CTL) response against the SSTR2-expressing cancer cells. The inclusion of an Fc domain on the antibody prolongs the half-life of the bispecific antibody.;

UNII : 88635FW2QX;

CAS number : 2148354-90-7; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2148354-90-7 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : XmAb 18087; XmAb-18087;

NCI Metathesaurus CUI : CL544867;

Details


You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.